Cargando…
CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
In October 2020, Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna won the Nobel Prize in Chemistry for their pioneering work in precise genome editing using the CRISPR technology. Although CRISPR technology has developed rapidly in the last decade, there are still many uncertainties before eventua...
Autores principales: | Li, Zi-Qing, Li, Chao-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722470/ https://www.ncbi.nlm.nih.gov/pubmed/33287895 http://dx.doi.org/10.1186/s40779-020-00292-2 |
Ejemplares similares
-
Lessons from a genome-wide CRISPR-Cas9 screening: what researchers should know before start
por: Masoudi, Mohammad
Publicado: (2021) -
Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians
por: Huerta-Alardín, Ana L, et al.
Publicado: (2005) -
Chyluria: what does the clinician need to know?
por: Stainer, Victoria, et al.
Publicado: (2020) -
Letter to the Editor regarding ‘COVID-19 and diabetes: What does the clinician need to know?’
por: Abbasi-Oshaghi, Ebrahim, et al.
Publicado: (2021) -
From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
por: Guo, Mu, et al.
Publicado: (2023)